The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

N/AActive Not RecruitingNCT07590570

Wenjin Yin188 enrolled

Overview

This is a multicentre study to investigate the association of fingernail lunula status with the efficacy and safety of neoadjuvant therapy in breast cancer patients.

Study Type

OBSERVATIONAL

Enrollment

188

Conditions

Breast Cancer Invasive

Interventions

neoadjuvant therapyDRUG

patients receiving neoadjuvant therapy

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 18 years or older * Pathologically confirmed invasive primary breast cancer * Patients who have received or are scheduled to receive neoadjuvant therapy Exclusion Criteria: * De novo stage IV breast cancer

Locations (1)

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, China

Outcomes

Primary Outcomes

Pathological Complete Response (pCR) Rate

ypT0 ypN0

Time frame: at surgery

Secondary Outcomes

Disease-free Survival

Disease-free survival time is defined as the time from date of randomization until the first occurrence of disease recurrence, distant metastasis and death from any cause.

Time frame: From surgery until time of event up to 8 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.